Unleashing a Lazarus Effect With Selpercatinib in a Never-Smoker Patient With Stage IV, Chemo-Immunotherapy Refractory, RET C630Y-Mutant, Small-Cell Lung Cancer: A First Case Report On the basis of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback